Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

Office of Drug Evaluation II (ODE II)

 

Our Mission - The Office of Drug Evaluation II is responsible for protecting the public health by assuring safe and effective drugs and biologics are available to the U.S. population for addiction, allergy, analgesia, anesthesia, diabetes, endocrine, metabolism, pulmonary, and rheumatological conditions. 
 
Immediate Office:
 
Director: Curtis J. Rosebraugh, M.D., M.P.H. 
Deputy Director: Christine Nguyen, M.D. (acting) 
Associate Director for Regulatory Affairs:  Vacant
Project Specialists: Velma Cunningham and Stanley Allen 
 

 

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Office of Drug Evaluation II
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2310
Fax: (301) 796-9717

-
-